Positive Phase II booster results for Lyme disease vaccine candidate
Valneva and Pfizer have reported positive Phase II results for a second booster dose of their vaccine candidate for Lyme disease.
Archives for September 3, 2024
FDA grants expanded approval for Emergent Bio’s mpox vaccine
The U.S. company Emergent BioSolutions recently announced the FDA approval of its application to expand the indication for ACAM2000 – previously approved for smallpox – to include the prevention of mpox in high-risk individuals.
Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind
As Orgenesis works to decentralize and democratize CAR-T therapies, its candidate therapy has shown complete response rates of more than 80% in a clinical study in China.